Table 1.
No. (%)* | |
---|---|
Primary prevention cohort of DCCT: | |
Conventional | 132 (48) |
Intensive | 146 (53) |
Secondary intervention cohort of DCCT: | |
Conventional | 138 (51) |
Intensive | 134 (49) |
Yrs diabetes: | |
Median or greater (21.75) | 290 (53) |
Less than median (21.75) | 260 (47) |
Hba1c: | |
First quartile (4.4–7.0) | 126 (23) |
Second quartile (7.0–7.6) | 149 (28) |
Third quartile (7.6–8.6) | 128 (24) |
Fourth quartile (8.6–13.6) | 135 (25) |
Attained age: | |
20–29 | 8 (2) |
30–39 | 169 (31) |
40–49 | 248 (45) |
50–59 | 125 (23) |
Current smoking | 74 (14) |
Body mass index (kg/m2): | |
Normal (less than 25) | 183 (34) |
Overweight (25–less than 30) | 222 (42) |
Obese (30 or greater) | 130 (24) |
Waist circumference (cm): | |
Median (82.2) or greater | 260 (50) |
Less than median (82.2) | 259 (50) |
Postmenopausal† | 124 (23) |
Prior hysterectomy‡ | 66 (12) |
Parity (No. live births): | |
0 | 165 (30) |
1 | 112 (20) |
2 or More | 273 (50) |
Peripheral neuropathy§ | 165 (32) |
Retinopathy:|| | |
None | 18 (3) |
Microaneurysm only | 143 (26) |
Very mild NPDR | 215 (39) |
Moderate or greater NPDR | 174 (31) |
Nephropathy EDIC yrs 9 + 10:¶ | |
Normal (AER less than 40) | 415 (76) |
Microalbuminuria (AER 40–less than 300) | 110 (20) |
Albuminuria (AER 300 or greater) | 25 (5) |
All totals that do not add up to 550 imply that the information is missing for those subjects.
Defined as a subject’s menstrual periods ceasing and considered permanent.
Defined as a subject’s menstrual period ceasing and considered permanent due to surgery.
Defined in EDIC by Michigan Neuropathy Screening Instrument as more than 6 positive responses on the questionnaire or a score greater than 2 on the examination.
Determined by Early Treatment Diabetic Retinopathy Study score.
EDIC years 9 and 10 have been combined to represent the entire study sample.